b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31650714</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>01</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>01</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1097-0339</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>48</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Feb</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Diagnostic cytopathology</Title>\n                <ISOAbbreviation>Diagn. Cytopathol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>111-117</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/dc.24331</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Micropapillary and plasmacytoid variants of urothelial carcinoma (UC) exhibit very aggressive clinical behavior. To date, only a small number of cytology cases have been reported in either of these variants. Herein, we report 15 cases of UC with combined micropapillary and plasmacytoid features based on urine cytology.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective analysis of all patients with carcinoma of bladder with predominant plasmacytoid and micropapillary histology who had been seen from 2005 to 2017. A total of 15 cases (six cases of plasmacytoid variant and nine cases of micropapillary variant of bladder cancer) with urine specimen were evaluated. The cytomorphological features were compared between two histological variants.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen urine cytology cases with the diagnosis of high-grade UC were investigated. The ratio man to women was 5:1 with a median age of 79\xe2\x80\x89years (range: 72-90\xe2\x80\x89years). Single-cell pattern, flat sheets, three-dimensional clusters, micropapillae, nuclear grade, cytoplasmic vacuoles, and necrosis, were evaluated in urine samples of micropapillary variant. The cytological features of plasmacytoid are characterized by large, discohesive, isolated tumor cells that have abundant, thick cytoplasm, and eccentrically located, hyperchromatic nuclei with coarse chromatin and inconspicuous nucleoli.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">It is important to recognize the cytological characteristics of these uncommon but aggressive entities to determine a precise diagnosis. Attention to morphological features, together with clinical history and appropriate immunohistochemical studies may be useful to urologist in pre-operative planning and may lead to a more aggressive surgical approach.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 Wiley Periodicals, Inc.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Straccia</LastName>\n                    <ForeName>Patrizia</ForeName>\n                    <Initials>P</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0003-3256-8293</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Anatomic Pathology and Histology, Universit\xc3\xa0 Cattolica del Sacro Cuore, Foundation &quot;A. Gemelli&quot; University Hospital, Largo Francesco Vito, Rome, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Martini</LastName>\n                    <ForeName>Maurizio</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Anatomic Pathology and Histology, Universit\xc3\xa0 Cattolica del Sacro Cuore, Foundation &quot;A. Gemelli&quot; University Hospital, Largo Francesco Vito, Rome, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sacco</LastName>\n                    <ForeName>Emilio</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Urologic Clinic, Department of Surgical Sciences, Universit\xc3\xa0 Cattolica del Sacro Cuore, Foundation &quot;A. Gemelli&quot; University Hospital, Largo Francesco Vito, Rome, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bassi</LastName>\n                    <ForeName>Pier F</ForeName>\n                    <Initials>PF</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Urologic Clinic, Department of Surgical Sciences, Universit\xc3\xa0 Cattolica del Sacro Cuore, Foundation &quot;A. Gemelli&quot; University Hospital, Largo Francesco Vito, Rome, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pierconti</LastName>\n                    <ForeName>Francesco</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Anatomic Pathology and Histology, Universit\xc3\xa0 Cattolica del Sacro Cuore, Foundation &quot;A. Gemelli&quot; University Hospital, Largo Francesco Vito, Rome, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>24</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Diagn Cytopathol</MedlineTA>\n            <NlmUniqueID>8506895</NlmUniqueID>\n            <ISSNLinking>1097-0339</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002291" MajorTopicYN="N">Carcinoma, Papillary</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010954" MajorTopicYN="N">Plasmacytoma</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019459" MajorTopicYN="N">Urothelium</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">micropapillary urothelial carcinoma</Keyword>\n            <Keyword MajorTopicYN="N">plasmacytoid urothelial carcinoma</Keyword>\n            <Keyword MajorTopicYN="N">urine cytology</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>16</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>6</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31650714</ArticleId>\n            <ArticleId IdType="doi">10.1002/dc.24331</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>REFERENCES</Title>\n            <Reference>\n                <Citation>Keck B, Stoehr R, Wach S, et al. The plasmacytoid carcinoma of the bladder rare variant of aggressive urothelial carcinoma. Int J Cancer. 2011;129(2):346-354.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Molek KR, Seili-Bekafigo I, \xc5\xa0temberger C, et al. Plasmacytoid urothelial carcinoma diagnostic challenge in cytology. Diagn Cytopathol. 2013;41(4):369-373.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhu B, Rohan SM, Lin X. Urine cytomorphology of micropapillary urothelial carcinoma. Diagn Cytopathol. 2013;41(6):485-491.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Amin MB, Ro RJ, El-Sharkawy T, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol. 1994;18:1224-1232.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Nassar H, Pansare V, Zhang H, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol. 2004;17:1045-1050.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Munakata S, Tahara H, Kojima K, Kishimoto T. Micropapillary urothelial carcinoma of the renal pelvis: report of a case and review of the literature. Med Sci Monit. 2007;13:CS47-CS52.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Barkan GA, Wojcik EM, Nayar R, et al. The Paris system for reporting urinary cytology: the quest to develop a standardized terminology. Adv Anat Pathol. 2016;23(4):193-201.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zukerberg LR, Harris NL, Young RH. Carcinomas of the urinary bladder simulating malignant lymphoma. A Report of Five Cases Am J Surg Pathol. 1991;15(6):569-576.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Humphrey PA, Moch H, Cubilla AL, et al. The 2016 WHO classification of Tumours of the urinary system and male genital organs-part B: prostate and bladder Tumours. Eur Urol. 2016;70(1):106-119.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Alvarado-Cabrero I, Sierra-Santiesteban FI, Mantilla-Morales A, Hernandez-Hernandez DM. Micropapillary carcinoma of the urothelial tract. A clinicopathologic study of 38 cases. Ann Diagn Pathol. 2005;9(1):1-5.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ylagan LR, Humphrey PA. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens. Acta Cytol. 2001;45:599-604.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lee JI. Micropapillary carcinoma of the urinary bladder: a case report. Acta Cytol. 2009;53:344-348.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary: a distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996;20(11):1319-1330.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Middleton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12(5):499-504.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma; a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002;26(3):358-364.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ching CB, Amin MB, Tubbs RR, et al. HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Mod Pathol. 2011;24(8):1111-1119.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Skagias L, Politi E, Karameris A, et al. Prognostic impact of HER2/neu protein in urothelial bladder cancer. Survival analysis of 80 cases and an overview of almost 20\xe2\x80\x89years\xe2\x80\x99 research. J BUON. 2009;14:457-462.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhang XM, Elhosseiny A, Melamed MR. Plasmacytoid urothelial carcinoma of the bladder. A case report and the first description of urinary cytology. Acta Cytol. 2002;46:412-416.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sakuma T, Furuta M, Mimura A, et al. Urine cytological findings of plasmacytoid urothelial carcinoma of urinary bladder: report of two cases. Cytopathology. 2009;20(4):264-267.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Al-Ahmadie HA, Iyer G, Lee BH, et al. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. Nat Genet. 2016;48:356-358.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315-322.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol. 1993;142:987-993.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Becker KF, Atkinson MJ, Reich U, et al. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet. 1993;2:803-804.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202-209.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Straccia P, Bizzarro T, Fadda G, Pierconti F. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris system for reporting urinary cytology. Cancer Cytopathol. 2016;124(7):519-523.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'